Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) COO Sells 5,209 Shares of Stock

Health Catalyst, Inc. (NASDAQ:HCAT) COO Daniel Lesueur sold 5,209 shares of the business’s stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $4.15, for a total transaction of $21,617.35. Following the completion of the sale, the chief operating officer now directly owns 211,041 shares in the company, valued at approximately $875,820.15. This trade represents a 2.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Daniel Lesueur also recently made the following trade(s):

• On Wednesday, March 5th, Daniel Lesueur sold 16,902 shares of Health Catalyst stock. The shares were sold at an average price of $4.52, for a total transaction of $76,397.04.
• On Wednesday, February 5th, Daniel Lesueur sold 5,209 shares of Health Catalyst stock. The stock was sold at an average price of $5.76, for a total value of $30,003.84.

Health Catalyst Stock Performance

Health Catalyst stock opened at $3.82 on Wednesday. Health Catalyst, Inc. has a fifty-two week low of $3.72 and a fifty-two week high of $9.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41. The stock has a market cap of $268.21 million, a P/E ratio of -2.83 and a beta of 1.43. The firm’s fifty day moving average price is $4.78 and its 200-day moving average price is $6.61.

Institutional Investors Weigh In On Health Catalyst

A number of large investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP bought a new position in shares of Health Catalyst during the 4th quarter valued at about $29,000. Group One Trading LLC grew its position in Health Catalyst by 107.6% during the fourth quarter. Group One Trading LLC now owns 4,360 shares of the company’s stock valued at $31,000 after acquiring an additional 2,260 shares during the last quarter. Aquatic Capital Management LLC bought a new position in Health Catalyst during the fourth quarter valued at approximately $63,000. Stoneridge Investment Partners LLC purchased a new position in shares of Health Catalyst during the fourth quarter worth approximately $77,000. Finally, Martin Worley Group bought a new stake in shares of Health Catalyst in the 4th quarter worth approximately $78,000. Hedge funds and other institutional investors own 85.00% of the company’s stock.

Wall Street Analysts Forecast Growth

HCAT has been the topic of a number of recent research reports. Citigroup dropped their price objective on Health Catalyst from $10.50 to $10.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Stifel Nicolaus cut their price objective on shares of Health Catalyst from $10.00 to $5.00 and set a “hold” rating for the company in a research report on Thursday, February 27th. Piper Sandler decreased their target price on shares of Health Catalyst from $12.00 to $8.00 and set an “overweight” rating on the stock in a report on Tuesday, February 11th. Wells Fargo & Company lowered their target price on shares of Health Catalyst from $13.00 to $10.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. Finally, KeyCorp upgraded shares of Health Catalyst from a “sector weight” rating to an “overweight” rating and set a $9.00 price target for the company in a research report on Wednesday, January 8th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $9.27.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.